======= SLC22A6 ======= == Gene Information == * **Official Symbol**: SLC22A6 * **Official Name**: solute carrier family 22 member 6 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=9356|9356]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q4U2R8|Q4U2R8]] * **Interactions**: [[https://thebiogrid.org/search.php?search=SLC22A6&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20SLC22A6|Open PubMed]] * **OMIM**: [[https://omim.org/entry/607582|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |MFS 1| |Sugar tr| |renal tubular secretion| |alpha-ketoglutarate transport| |response to methotrexate| |organic anion transmembrane transporter activity| |chloride ion binding| |inorganic anion exchanger activity| |response to antimetabolite| |sodium-independent organic anion transmembrane transporter activity| |sodium-independent organic anion transport| |anion:anion antiporter activity| |cofactor transport| |caveola| |dicarboxylic acid transport| |response to antineoplastic agent| |renal system process| |inorganic anion transport| |basolateral plasma membrane| |anion transmembrane transport| |carboxylic acid transport| |organic acid transport| |protein homooligomerization| |response to acid chemical| |organic anion transport| |protein complex oligomerization| |anion transport| |protein-containing complex| |protein homodimerization activity| |response to organic cyclic compound| |ion transmembrane transport| |response to organonitrogen compound| |response to drug| |response to nitrogen compound| |secretion| |transmembrane transport| |ion transport| |integral component of plasma membrane| |response to oxygen-containing compound| |protein-containing complex assembly| |protein-containing complex subunit organization| |system process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp15|Cycloheximide 0.2μM R00 exp15]]|1.72| |[[:results:exp224|CB-839 10μM R05 exp224]]|1.76| |[[:results:exp239|PFI-2 4μM R05 exp239]]|1.87| |[[:results:exp425|Beta-Estradiol 0.55μM R07 exp425]]|2.07| ^Gene^Correlation^ |[[:human genes:k:kctd17|KCTD17]]|0.409| |[[:human genes:s:slc4a1|SLC4A1]]|0.407| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 2404 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}